Publications by authors named "J Colomba"
Background & Aims: Cystic fibrosis (CF)-related diabetes (CFRD), a common comorbidity in CF, is often preceded and characterized with elevated postprandial glycemic (PPG) excursions. In the general population, the consumption of a pre-meal protein snack and/or physical activity (PA) hinder the elevation of PPG levels. Our objective is to evaluate the effect of a pre-meal snack and/or post-meal PA on PPG excursions in CF.
View Article and Find Full Text PDFArticle Synopsis
- - Cystic fibrosis-related diabetes (CFRD) is a common issue in cystic fibrosis patients, characterized by normal fasting blood glucose but problematic post-meal glucose levels, which can worsen health outcomes.
- - This study aimed to test whether soluble fiber supplements could lower post-prandial glucose levels in cystic fibrosis patients with glucose intolerance or CFRD through a double-blind crossover approach with three different interventions.
- - Results showed that fiber supplementation did not improve post-prandial glucose control; however, all participants had lower blood glucose levels after lunch compared to breakfast, despite consuming more carbohydrates.
Article Synopsis
- The study aimed to determine if COVID-19 severity and death rates among patients with cancer improved over time during the pandemic.
- It utilized data from the OnCovid registry, which included nearly 2,800 patients with various types of cancer from 6 European countries, focusing on patient outcomes from February 2020 to February 2021.
- Results showed that the 14-day case-fatality rate significantly decreased over time, suggesting improved management and outcomes for cancer patients infected with COVID-19.
Article Synopsis
- The study investigates the impact of COVID-19 on cancer patients, focusing on the prevalence of long-term effects (sequelae) and their influence on patient survival.
- The research involved 2,634 eligible cancer patients who had confirmed SARS-CoV-2 infections and were assessed several months after recovery to analyze their health outcomes.
- Results showed 1,557 COVID-19 survivors underwent a formal reassessment about 22 months post-cancer diagnosis, revealing insights into the effects of COVID-19 on their treatment and survival.